Abstract 1667P
Background
Immune checkpoint inhibitor (ICI) colitis is among the most prevalent immune-related adverse events (irAEs) of immune checkpoint blockade (ICB). Deeper pathophysiological understanding can contribute to evidence-based management of ICI colitis. While single-cell RNA sequencing studies lack tissue architectural insight, we used imaging mass cytometry (IMC) to study ICI colitis spatially in high immunological detail.
Methods
Formalin-fixed paraffin embedded colon biopsies of 18 patients with ICI colitis (4 αCTLA-4, 5 αPD-1, 9 combined [C]ICB) and 5 patients with ulcerative colitis were included. After DAPI imaging of nuclei, IMC was performed on ∼1 mm2 regions of stained tissue. Cells were segmented with the MATISSE pipeline combining DAPI and IMC data. We developed a data normalization, data clean-up and supervised cell lineage determination pipeline. To consolidate tissue findings, serum proteomic data (Olink® Target 96 Immuno-Oncology panel) in a partially overlapping cohort of 80 ICB-treated patients, of whom 14 with ICI colitis, were included. All P values are corrected for multiple testing.
Results
CD8+ T cells (CD8s) dominated the infiltrate of both αPD-1 and CICB colitis. CICB colitis showed the highest CD8 granzyme B (GzmB) production across groups (P < .01). Considering only the 14 patients with ICI colitis in the proteomics cohort, serum GzmB was also higher in CICB than αPD-1 colitis. A mixed-effects model showed that activated CD8s with CD69hiCD103hi tissue resident (TRM) like phenotype, more abundant in epithelium than lamina propria, mainly explained high GzmB levels in CICB colitis. CTCAE grade colitis had no effect. Within the CD4+ pool, we found elevated TH1/TH17 balance in CICB vs αCTLA-4 (P = .04), with αPD-1 TH1/TH17 balance in between αCTLA-4 and CICB. Consistently, TH1-associated serum protein levels of IFN-γ, TNF-α, GzmB/H/A and IL12Rβ1 were increased in CICB vs αPD-1 patients with any high-grade irAE (all P < .05).
Conclusions
Our data demonstrate that epithelial cytotoxic CD8+ TRM cells, as well as local TH1 skewing, are associated with the highest cytotoxicity in CICB colitis. These findings indicate that tissue TRM cells are direct targets of ICB and play an important role in colitis development.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Dutch Society of Gastroenterology (NVGE; Gastrostart grant).
Disclosure
K.P.M. Suijkerbuijk: Financial Interests, Institutional, Advisory Board: Novartis, BMS, AbbVie, Pierre Fabre, MSD; Financial Interests, Institutional, Invited Speaker: Roche; Financial Interests, Institutional, Research Grant: Novartis, TigaTx. All other authors have declared no conflicts of interest.